{"acquisitions":[],"changes":[],"country":"US","description":"Plakous Therapeutics develops human-placental-extract biotherapeutics with anti-inflammatory and cell-proliferation activity. Lead programmes target paediatric necrotising enterocolitis and infant malabsorption with rare-paediatric and orphan-drug designations. The platform repositions birth-tissue extracts as a regenerative-medicine class.","domain":"plakoustherapeutics.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":36.099813,"lng":-80.244052,"location":"WINSTON SALEM, North Carolina","multiples":[],"name":"PLAKOUS THERAPEUTICS, INC.","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":2098219,"connectionsAmong":[],"currency":"USD","date":"2024-01-01","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"plakoustherapeutics-com-2024-01-01-grant","source":{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-08","status":"attributed","url":null},"status":"attributed","type":"grant","url":null}],"slug":"plakoustherapeutics-com","sources":[{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-08","status":"attributed","url":null},{"fact":"existence","publisher":"plakoustherapeutics.com","retrievedAt":"2026-05-08","status":"self-reported","url":"https://plakoustherapeutics.com"},{"fact":"description","publisher":"plakoustherapeutics.com","retrievedAt":"2026-05-08","status":"self-reported","url":"https://plakoustherapeutics.com"}],"stage":null,"stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":["Nginx","WordPress","Typekit","Adobe Fonts","AitThemes","MonsterInsights 10.1.3","Yoast SEO 27.5","reCAPTCHA","Google Analytics","Google Tag Manager","Gravity Forms 2.10.1","jQuery Migrate 3.4.1"],"totalRaisedUsd":2098219,"traction":[],"updatedAt":"2026-05-08","valuations":[]}